Watchlist Price Alert

West Pharmaceutical Servi... (WST)

NYSE: WST · Real-Time Price · USD

221.49

-2.81 (-1.25%)

At close: Jun 17, 2025, 10:50 AM

West Pharmaceutical Services Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	484.6M	853.9M	894.3M	762.6M	615.5M	439.1M	337.4M	235.9M	203M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	202.1M	210M	204.9M	207.7M	214.7M	192.7M	91.2M	85.8M	82.7M
Other Long-Term Assets	74.2M	21.3M	38.4M	55.9M	36.3M	29M	20.5M	23.4M	21.3M
Receivables	552.5M	512M	507.4M	489M	385.3M	319.3M	288.2M	253.2M	200.5M
Inventory	377M	434.7M	414.8M	378.4M	321.3M	235.7M	214.5M	215.2M	199.3M
Other Current Assets	124M	135.8M	103M	112M	51.6M	64.6M	54.3M	39.2M	39.1M
Total Current Assets	1.54B	1.94B	1.92B	1.74B	1.37B	1.06B	894.4M	743.5M	641.9M
Property-Plant & Equipment	1.69B	1.51B	1.26B	1.13B	1.01B	909.4M	822M	855M	778.3M
Goodwill & Intangibles	116.9M	123.6M	125.7M	132.9M	141.6M	137.6M	126.2M	129.4M	126.3M
Total Long-Term Assets	2.11B	1.89B	1.7B	1.57B	1.42B	1.28B	1.08B	1.12B	1.07B
Total Assets	3.64B	3.83B	3.62B	3.31B	2.79B	2.34B	1.59B	1.86B	1.72B
Account Payables	239.3M	242.4M	215.4M	232.2M	213.1M	156.8M	130.4M	138.1M	122M
Deferred Revenue	49.6M	41.7M	57.3M	48.7M	51M	27.5M	25.5M	18.4M	13.2M
Short-Term Debt	-4.2M	134M	18.2M	53.5M	12.4M	11.9M	100K	n/a	2.4M
Other Current Liabilities	67.4M	100M	95.3M	88.5M	93.8M	43.9M	51.1M	58.6M	47.3M
Total Current Liabilities	550.4M	671.8M	519M	594.1M	503.4M	341.6M	283.7M	279.5M	241M
Long-Term Debt	202.6M	72.8M	206.7M	208.8M	252.9M	255M	196M	197M	226.2M
Other Long-Term Liabilities	105.8M	106.7M	98.9M	107.6M	112.2M	93.7M	89.8M	96M	122.8M
Total Long-Term Liabilities	410.7M	276.7M	412.9M	384.3M	435.9M	426.6M	298.9M	303.4M	358.2M
Total Liabilities	961.1M	948.5M	931.9M	978.4M	939.3M	768.2M	196.1M	197M	228.6M
Total Debt	302.3M	309M	317.9M	325.3M	325.7M	329.3M	196.1M	197M	228.6M
Common Stock	18.8M	18.8M	18.8M	18.8M	18.8M	18.8M	18.8M	18.8M	18.4M
Retained Earnings	3.96B	3.52B	2.99B	2.46B	1.85B	1.55B	1.35B	1.18B	1.07B
Comprehensive Income	-258.1M	-143.8M	-183M	-159.6M	-110.6M	-149.6M	-154.2M	-117.3M	-186.8M
Shareholders Equity	2.68B	2.88B	2.68B	2.34B	1.85B	1.57B	1.4B	1.28B	1.12B
Total Investments	202.1M	210M	204.9M	207.7M	214.7M	192.7M	91.2M	85.8M	82.7M